Yung‐Mae Yao

2.0k total citations
25 papers, 1.2k citations indexed

About

Yung‐Mae Yao is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yung‐Mae Yao has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yung‐Mae Yao's work include Advanced biosensing and bioanalysis techniques (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Epigenetics and DNA Methylation (3 papers). Yung‐Mae Yao is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Epigenetics and DNA Methylation (3 papers). Yung‐Mae Yao collaborates with scholars based in United States, Switzerland and Germany. Yung‐Mae Yao's co-authors include Michael Hall, Alice Loo, Frank Stegmeier, William R. Sellers, Marion Dorsch, Susan Wee, Kay X. Xiang, Christoph Lengauer, Zainab Jagani and Naheed A. Mufti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Circulation Research.

In The Last Decade

Yung‐Mae Yao

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yung‐Mae Yao

Since Specialization

Citations

This map shows the geographic impact of Yung‐Mae Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yung‐Mae Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yung‐Mae Yao more than expected).

Fields of papers citing papers by Yung‐Mae Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yung‐Mae Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yung‐Mae Yao. The network helps show where Yung‐Mae Yao may publish in the future.

Co-authorship network of co-authors of Yung‐Mae Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yung‐Mae Yao. A scholar is included among the top collaborators of Yung‐Mae Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yung‐Mae Yao. Yung‐Mae Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 4835: LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions 2019 ·David Surguladze, (unknown), Xiaodi Ren, (unknown), Alan S. Rigby, Paul Balderes, Elizabeth Navarro, Nelusha Amaladas, Scott Eastman, Michael J. Topper, Yung‐Mae Yao, (unknown), Gregory D. Plowman, Dale L. Ludwig	1
2	Abstract 3632: Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models 2018 ·Cancer Research ·(unknown), Amélie Forest, (unknown), David Schaer, Ting Chen, Shengwu Liu, David Surguladze, Yung‐Mae Yao, Thompson N. Doman, Gerald E. Hall, Kwok‐Kin Wong, Michael Kalos, Ruslan D. Novosiadly	1
3	VX-322: A Novel Dual Receptor Tyrosine Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia 2012 ·Journal of Medicinal Chemistry ·David K. Heidary, George Q. Huang, Diane M. Boucher, Jianguo Ma, Cornelia J. Forster, (unknown), (unknown), (unknown), Deborah M. Choquette, Guanjing Chen, Jiehua Zhou, Yung‐Mae Yao, Edward D. Ball, Mark Namchuk, Robert J.O. Davies, Greg Henkel	15
4	Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas 2011 ·Cancer Research ·Tara L. Naylor, Huaping Tang, Boris A. Ratsch, Andreas Enns, Alice Loo, Liqing Chen, Peter Lenz, Nigel J. Waters, W. Schüler, Bernd Dörken, Yung‐Mae Yao, Markus Warmuth, Georg Lenz, Frank Stegmeier	88
5	Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T‐cell lymphoma models: Defining molecular mechanisms of resistance 2010 ·International Journal of Cancer ·Wenlin Shao, Joseph D. Growney, Yun Feng, Gregory O’Connor, Minying Pu, Wenjing Zhu, Yung‐Mae Yao, Paul Kwon, Stephen E. Fawell, Peter Atadja	77
6	Abstract 4290: The smoothened antagonist NVP-LDE225 targets stroma and cancer stem cells in primary human pancreatic tumor xenografts 2010 ·Cancer Research ·Silvia Buonamici, Beatriz Muñoz, (unknown), Jing Yuan, Kathy Hsiao, Anthony Vattay, Fang Li, James Deeds, Lance Ostrom, John E. Monahan, Juliet Williams, Joseph F. Kelleher, Stefan Peukert, Shifeng Pan, Xu Wu, Markus Warmuth, Rebecca Mosher, Yung‐Mae Yao, William R. Sellers, Marion Dorsch	4
7	PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers 2009 ·Cancer Research ·Susan Wee, Zainab Jagani, Kay X. Xiang, Alice Loo, Marion Dorsch, Yung‐Mae Yao, William R. Sellers, Christoph Lengauer, Frank Stegmeier	354
8	Abstract B27: Correlation between TNFα and LCL161 anti-tumor activity in patient derived xenograft models of human cancer 2009 ·Molecular Cancer Therapeutics ·Brant Firestone, (unknown), Guizhi Yang, Hui Gao, Dale Porter, Joanna Slisz, Dan He, Rebecca Mosher, John E. Monahan, Christopher Straub, Michael Morrissey, Yung‐Mae Yao, Leigh Zawel	11
9	Potent anticancer activity of the pan-deacetylase inhibitor panobinostat (LBH589) as a single agent in in vitro and in vivo tumor models 2008 ·Cancer Research ·Wenlin Shao, Joseph D. Growney, Yun Feng, Ping Wang, Yan Yan‐Neale, Gregory O’Connor, Paul Kwon, Yung‐Mae Yao, Stephen E. Fawell, Peter Atadja	15
10	BHQ880, a novel anti-DKK1 neutralizing antibody, inhibits tumor-induced osteolytic bone disease 2008 ·Cancer Research ·Seth A. Ettenberg, Feng Cong, Janine Shulok, Stefanie Urlinger, (unknown), Olga Charlat, Yuji Mishina, Shanming Liu, Mike Daley, Sharon Li, (unknown), Georges Rawadi, Philippe Clément-Lacroix, Patrick Mollat, Youzhen Wang, Yung‐Mae Yao, David R. Stover	5
11	Potent anticancer activity of the deacetylase inhibitor panobinostat (LBH589) in colon cancer cell lines and patient-derived primary colon cancer xenografts 2008 ·Cancer Research ·Youzhen Wang, Joseph D. Growney, Jane Cheng, Colleen Kowal, Guizhi Yang, Rebecca Mosher, Ronald A. Meyer, Yan Yan‐Neale, Minying Pu, Wenlin Shao, Yun Feng, Paul Kwon, Peter Atadja, Stephen E. Fawell, Yung‐Mae Yao	2
12	Efficacy of Panobinostat (LBH589) in CTCL Cell Lines and a Murine Xenograft Model: Defining Molecular Pathways of Panobinostat Activity in CTCL. 2007 ·Blood ·Wenlin Shao, Joseph D. Growney, Yun Feng, Gregory O’Connor, Minying Pu, Yung‐Mae Yao, Paul Kwon, Stephen E. Fawell, Peter Atadja	4
13	Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma. 2007 ·Blood ·Joseph D. Growney, Peter Atadja, Wenlin Shao, Youzhen Wang, Minying Pu, Brant Firestone, Jane Cheng, Colleen Kowal, Christine Miller, Joseph Eckman, Yung‐Mae Yao, Stephen E. Fawell, Andrew Spencer, Jesús F. San Miguel, Kenneth C. Anderson	3
14	c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo 2005 ·Circulation Research ·Zhili Shao, Kausik Bhattacharya, Eileen Hsich, Larry Park, Brian Walters, Ursula A. Germann, Yow‐Ming Wang, John Kyriakis, Ramon Mohanlal, Keisuke Kuida, Mark Namchuk, Francesco G. Salituro, Yung‐Mae Yao, Weimin Hou, Xin Chen, Mark Aronovitz, Philip N. Tsichlis, Susmita Bhattacharya, Thomas Force, Heiko Kilter	106
15	The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model. 2004 ·Blood ·Jugnu Jain, Jianguo Ma, Brinley F. Furey, Christian Récher, Cécile Demur, Srinivasu Poondru, Jianbo Zhang, Shaolan Li, Brant Firestone, Karen A. Olson, (unknown), Jennifer M. Taylor, Greg Henkel, Edward D. Ball, Yung‐Mae Yao, Susan J. Almquist, Russell R. Hoover	3
16	Upconverting Phosphor Reporters in Immunochromatographic Assays 2001 ·Analytical Biochemistry ·Johannes Hampl, Michael Hall, Naheed A. Mufti, Yung‐Mae Yao, David MacQueen, W. H. Wright, David E. Cooper	231
17	High Sensitivity Immunoassays Using Particulate Fluorescent Labels 1999 ·Analytical Biochemistry ·Michael Hall, (unknown), Yung‐Mae Yao	55
18	<title>Detection of DNA using upconverting phosphor reporter probes</title> 1997 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·(unknown), Yung‐Mae Yao, Naheed A. Mufti, (unknown)	4
19	Isolation and characterization of a cDNA that encodes an agrin homolog in the marine ray 1992 ·Molecular and Cellular Neuroscience ·(unknown), (unknown), Fabio Rupp, Yung‐Mae Yao, James W. Schilling, Peter M. Snow, U.J. McMahan	48
20	Identification of Agrin in Electric Organ Extracts and Localization of Agrin-Like Molecules in Muscle and Central Nervous System 1987 ·Journal of Experimental Biology ·Martin A. Smith, Yung‐Mae Yao, Noreen E. Reist, (unknown), Bruce G. Wallace, U.J. McMahan	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact